Tissue plasminogen activator prevents white matter damage following stroke
Open Access
- 16 May 2011
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 208 (6), 1229-1242
- https://doi.org/10.1084/jem.20101880
Abstract
Tissue plasminogen activator (tPA) is the only available treatment for acute stroke. In addition to its vascular fibrinolytic action, tPA exerts various effects within the brain, ranging from synaptic plasticity to control of cell fate. To date, the influence of tPA in the ischemic brain has only been investigated on neuronal, microglial, and endothelial fate. We addressed the mechanism of action of tPA on oligodendrocyte (OL) survival and on the extent of white matter lesions in stroke. We also investigated the impact of aging on these processes. We observed that, in parallel to reduced levels of tPA in OLs, white matter gets more susceptible to ischemia in old mice. Interestingly, tPA protects murine and human OLs from apoptosis through an unexpected cytokine-like effect by the virtue of its epidermal growth factor-like domain. When injected into aged animals, tPA, although toxic to the gray matter, rescues white matter from ischemia independently of its proteolytic activity. These studies reveal a novel mechanism of action of tPA and unveil OL as a target cell for cytokine effects of tPA in brain diseases. They show overall that tPA protects white matter from stroke-induced lesions, an effect which may contribute to the global benefit of tPA-based stroke treatment.Keywords
This publication has 55 references indexed in Scilit:
- Experimental models for analysis of oligodendrocyte pathophysiology in strokeExperimental & Translational Stroke Medicine, 2009
- Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impactBrain, 2009
- Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic StrokeStroke, 2009
- Ischemic Injury to White Matter: An Age-Dependent ProcessThe Neuroscientist, 2009
- Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1Journal of Neuroscience, 2008
- Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2The American Journal of Pathology, 2007
- Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cellsGut, 2007
- Maturation-dependent oligodendrocyte apoptosis caused by hyperoxiaJournal of Neuroscience Research, 2006
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Caspases determine the vulnerability of oligodendrocytes in the ischemic brainJCI Insight, 2000